Facebook tracking pixel
Z86.39
ICD-10-CM
History of Hyperlipidemia

Understanding the history of hyperlipidemia is crucial for accurate diagnosis and treatment. This resource covers clinical documentation requirements for hyperlipidemia, including ICD-10 codes, family history of high cholesterol, lipid panel results, and past medical history of dyslipidemia. Learn about documenting statin use, lifestyle modifications, and other relevant details for comprehensive healthcare records and optimized medical coding. Explore resources for effective hyperlipidemia management and improved patient outcomes.

Also known as

Past Hyperlipidemia
Resolved Hyperlipidemia

Diagnosis Snapshot

Key Facts
  • Definition : Persistently elevated levels of fats (lipids) in the blood.
  • Clinical Signs : Often asymptomatic, but high cholesterol can lead to heart disease, stroke, and pancreatitis.
  • Common Settings : Primary care, cardiology, endocrinology clinics. Diagnosed via blood lipid panel.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC Z86.39 Coding
E78.0-E78.9

Pure hypercholesterolemia

Elevated cholesterol levels without other lipid abnormalities.

E78.1

Pure hyperglyceridemia

Elevated triglycerides with normal cholesterol levels.

E78.2

Mixed hyperlipidemia

Elevated cholesterol and triglyceride levels.

Z87.4

Personal history of hyperlipidemia

Past diagnosis of hyperlipidemia, currently resolved or controlled.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the hyperlipidemia currently present?

  • Yes

    Do NOT code history of hyperlipidemia. Code the active hyperlipidemia (e.g., E78.0, E78.1, E78.2, E78.5).

  • No

    Is there any documented past diagnosis?

Code Comparison

Related Codes Comparison

When to use each related code

Description
History of hyperlipidemia
Pure hypercholesterolemia
Mixed hyperlipidemia

Documentation Best Practices

Documentation Checklist
  • ICD-10 E78.5 documented
  • Onset date of hyperlipidemia
  • Type of hyperlipidemia (primary, secondary)
  • LDL, HDL, Triglycerides levels recorded
  • Treatment plan for hyperlipidemia noted

Coding and Audit Risks

Common Risks
  • Unconfirmed Diagnosis

    Coding hyperlipidemia without sufficient documentation like lab results or provider confirmation leads to inaccurate coding and potential denial of claims.

  • Unspecified Type

    Lack of specificity (e.g., mixed, pure) when coding hyperlipidemia can affect risk adjustment and reimbursement accuracy. CDI crucial for detail.

  • Status Miscoding

    Confusing history of with current hyperlipidemia or failing to distinguish controlled vs uncontrolled status impacts data integrity and quality reporting.

Mitigation Tips

Best Practices
  • Document LDL, HDL, triglycerides with units & dates.
  • Code hyperlipidemia type: primary, secondary, familial.
  • Capture medication, diet, exercise interventions.
  • Query physician for unspecified hyperlipidemia details.
  • Ensure ICD-10-CM coding aligns with clinical findings.

Clinical Decision Support

Checklist
  • Review LDL, HDL, triglycerides levels documented.
  • Confirm patient history and family history of hyperlipidemia.
  • Assess for secondary causes medicationdietlifestyle.
  • Check for documented treatment plan including lifestyle modifications andor medication.
  • Evaluate patient adherence to treatment and effectiveness.

Reimbursement and Quality Metrics

Impact Summary
  • Hyperlipidemia Diagnosis Reimbursement: ICD-10 E78.5 affects MS-DRG assignment and impacts reimbursement rates. Accurate coding crucial for maximizing hospital revenue.
  • Quality Metrics Impact: HEDIS measures track cholesterol management in patients with hyperlipidemia, impacting hospital quality scores and value-based payments.
  • Coding Accuracy: Proper documentation and coding of hyperlipidemia, including severity and type, essential for accurate risk adjustment and avoiding denials.
  • Hospital Reporting: Precise hyperlipidemia coding improves data accuracy for public health reporting, disease management programs, and clinical research.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How does a detailed family history of hyperlipidemia inform my diagnostic approach and management plan?

A: A detailed family history of hyperlipidemia, including the age of onset, specific lipid abnormalities (e.g., high LDL cholesterol, low HDL cholesterol, high triglycerides), and any associated cardiovascular events, is crucial for risk stratification and personalized management. Early-onset familial hypercholesterolemia (FH) can manifest differently than polygenic hyperlipidemia and may warrant genetic testing. Identifying a pattern of premature cardiovascular disease in the family history can signal the need for more aggressive lipid-lowering therapy, even in patients with moderately elevated lipid levels. Explore how incorporating family history data can refine your diagnostic process and guide treatment decisions for patients with hyperlipidemia. Consider implementing a standardized family history questionnaire to ensure comprehensive data collection.

Q: What are the key differences in diagnosing hyperlipidemia between adults and children, and what specific considerations should I keep in mind for pediatric patients?

A: Diagnosing hyperlipidemia in children differs significantly from adults. Universal lipid screening is recommended for children aged 9-11 and again at 17-21, while selective screening may be appropriate for younger children with a family history of dyslipidemia or premature cardiovascular disease. Pediatric thresholds for lipid levels are lower than in adults, reflecting the long-term impact of elevated lipids on cardiovascular risk. Furthermore, identifying specific causes of secondary hyperlipidemia, such as nephrotic syndrome or hypothyroidism, is crucial in children. Learn more about the specific guidelines for lipid screening and management in pediatric populations to ensure appropriate diagnosis and intervention. Consider implementing age-specific protocols for lipid management in your practice.

Quick Tips

Practical Coding Tips
  • Document LDL, HDL, triglycerides
  • Code E78.5 for hyperlipidemia
  • Query physician if unspecified
  • Family history impacts coding
  • Check ICD-10 guidelines annually

Documentation Templates

Patient presents with a history of hyperlipidemia, diagnosed in [Date of Diagnosis] with initial presentation of [Initial Presenting Symptoms, e.g., elevated cholesterol on routine screening, or symptoms related to atherosclerotic complications].  Past medical history includes [List relevant medical history, e.g., hypertension, coronary artery disease, diabetes mellitus, family history of dyslipidemia].  Current medications include [List current medications including lipid-lowering agents such as statins, fibrates, niacin, bile acid sequestrants, or PCSK9 inhibitors, as well as other medications relevant to the patient's overall health].  Review of systems reveals [Document pertinent findings related to hyperlipidemia and its potential complications, e.g., xanthomas, xanthelasmas, abdominal pain suggestive of pancreatitis, chest pain suggestive of angina, symptoms of peripheral artery disease].  Physical exam findings include [Document relevant physical findings, e.g.,  blood pressure, body mass index (BMI), presence or absence of xanthomas or xanthelasmas, auscultation of the heart and lungs, assessment of peripheral pulses].  Laboratory results show [Include lipid panel results including total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and non-HDL cholesterol].  Assessment:  History of hyperlipidemia.  ICD-10 code: E78.5.  Differential diagnoses considered include [Consider and document relevant differential diagnoses, e.g., familial hypercholesterolemia, secondary dyslipidemia due to medications or underlying medical conditions].  Plan:  Continue current lipid-lowering therapy with [Medication name and dosage].  Discussed lifestyle modifications including diet, exercise, and weight management.  Patient education provided on the importance of medication adherence and follow-up appointments.  Scheduled follow-up in [Timeframe] to reassess lipid profile and monitor for treatment efficacy and potential adverse effects.  Patient understands and agrees with the plan.
History of Hyperlipidemia - AI-Powered ICD-10 Documentation